August 18, 2015
UNC Lineberger member Frances Collichio, MD, was an investigator for a clinical trial for a treatment that uses a modified virus against melanoma. The treatment meant remission for Willis Davis, who had been diagnosed with stage IIIc melanoma in 2009.
August 13, 2015
In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.
June 10, 2015
UNC Lineberger will be enrolling patients into a new, national clinical trial, known as NCI-MATCH, that will group patients based on the genetics of their tumors as opposed to where their cancer is located. The new initiative will test more than 20 drugs or drug combinations targeting specific genetic mutations.
May 27, 2015
UNC Lineberger member Michael R. Kosorok, PhD, W.R. Kenan Jr. Distinguished Professor and chair of biostatistics at UNC’s Gillings School of Global Public Health, is the contact principal investigator for an multi-institution effort to continue to find ways to develop more powerful clinical trials for cancer patients. The project is backed by a five-year, $10.4 million grant from the National Cancer Institute.
April 12, 2015
UNC Lineberger Comprehensive Cancer Center researchers will share their study findings and expertise at the American Association for Cancer Research’s annual meeting, which is expected to draw thousands to Philadelphia April 18-22 to discuss advances in cancer science.
March 30, 2015
Results from a UNC Lineberger-led study were published Monday in the journal Molecular Cancer Therapeutics. The pre-clinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it's spread to the brain.
March 3, 2015
The American Cancer Society has honored Hyman B. Muss, MD, director of the UNC Lineberger Comprehensive Cancer Center Geriatric Oncology Program, with a prestigious national award that recognizes providers who show compassion and dedication beyond the call of duty.
February 5, 2015
One of nation’s top universities yields more than 150 startup companies to date, including G1 Therapeutics, creating jobs and advancing innovation and entrepreneurship.
October 8, 2014
CHAPEL HILL, NC – Matthew Milowsky, MD, associate professor and co-director of the Urologic Oncology Program at UNC Lineberger Comprehensive Cancer Center, has been appointed as the clinic medical director of the N.C. Cancer Hospital.
September 4, 2014
UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.
